As a result, we sought new methods to enhance DC activity for adoptive transfer by manipulating this balance using constitutively active mutant DAP12 and demonstrated that transduction of constitutively active DAP12 mutants into primary MoDCs leads to active, functional, and responsive DCs, that induce significant antitumor effects in a B16 murine melanoma model. Here, TYROBP is linked to melanoma.